Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Ali A, Hoyle A, Haran ÁM, Brawley CD, Cook A, Amos C, Calvert J, Douis H, Mason MD, Dearnaley D, Attard G, Gillessen S, Parmar MKB, Parker CC, Sydes MR, James ND, Clarke NW.
JAMA Oncol. 2021 Apr 1;7(4):555-563. doi: 10.1001/jamaoncol.2020.7857.
Myeloid Cells in Metastasis.
Swierczak A, Pollard JW.
Cold Spring Harb Perspect Med. 2020 May 1;10(5):a038026. doi: 10.1101/cshperspect.a038026.
Cervical tumors.
Sahdev A.
Semin Ultrasound CT MR. 2010 Oct;31(5):399-413. doi: 10.1053/j.sult.2010.07.004.
Local Therapeutics for the Treatment of Oligo Metastatic Prostate Cancer.
Jalfon MJ, Sakhalkar OV, Lokeshwar SD, Marks VA, Choksi AU, Klaassen Z, Leapman MS, Kim IY.
Curr Urol Rep. 2023 Oct;24(10):455-461. doi: 10.1007/s11934-023-01173-6. Epub 2023 Jun 28.
Paraganglioma with a very rare presentation.
Khare M, Gupta MK, Sharma UB, Garg KM.
Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):404-406. doi: 10.4103/IJPM.IJPM_334_17.
Secondary Tumors of the Gynecologic Tract: A Clinicopathologic Analysis.
Karpathiou G, Chauleur C, Hathroubi S, Peoc'h M.
Int J Gynecol Pathol. 2019 Jul;38(4):363-370. doi: 10.1097/PGP.0000000000000516.
Malignant Sertoli cell tumor of testicle.
Godec CJ.
Urology. 1985 Aug;26(2):185-8. doi: 10.1016/0090-4295(85)90061-5.
Emerging role for local therapy in oligometastatic prostate cancer.
Khondakar NR, Owens-Walton J, Daneshvar M, Williams C, O'Connor L, Yerram NK, Pinto PA.
Clin Adv Hematol Oncol. 2021 Jul;19(7):460-467.
Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis.
Lin SR, Mokgautsi N, Liu YN.
Molecules. 2020 May 20;25(10):2380. doi: 10.3390/molecules25102380.
Clinical variability and molecular heterogeneity in prostate cancer.
Shoag J, Barbieri CE.
Asian J Androl. 2016 Jul-Aug;18(4):543-8. doi: 10.4103/1008-682X.178852.
